This inventor holds 8 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 2006-2009.
Company Filing History:
Years Active: 2006-2009
Title: Michelle Schaffer: Innovator in IGF-1 Research
Introduction
Michelle Schaffer is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biochemistry, particularly in the study of insulin-like growth factor-1 (IGF-1). With a total of 8 patents to her name, her work has implications for various medical applications.
Latest Patents
One of her latest patents is focused on the crystallization of IGF-1. This patent provides a method for producing crystalline IGF-1, which involves mixing an aqueous solution containing IGF-1 with a reservoir solution that includes a precipitant. The process culminates in the crystallization of the mixture, with options for recrystallization and isolation of the crystalline IGF-1. Additionally, she has developed a method for identifying IGF-1 indirect agonists, utilizing a detergent as a standard for measuring the inhibition of binding of IGFBP-1 or IGFBP-3 to IGF-1. This method also employs the coordinates of the binding pockets of IGF-1 for structure-based drug design. Another significant patent involves the use of IGF-1-antagonist peptides that inhibit the interaction of IGF-1 with its binding proteins and receptors, which can be beneficial in treating disorders where IGF-1 plays a causative role, such as various cancers.
Career Highlights
Michelle Schaffer is currently associated with Genentech, Inc., where she continues her innovative research. Her work has not only advanced scientific understanding but also paved the way for potential therapeutic applications.
Collaborations
Throughout her career, Michelle has collaborated with notable colleagues, including Mark Ultsch and Felix Vajdos. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Michelle Schaffer stands out as a leading inventor in the realm of IGF-1 research, with her patents reflecting her commitment to advancing medical science. Her innovative approaches have the potential to impact various therapeutic areas significantly.